Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis

Author:

Bolfi F1,Neves A F1,Boguszewski C L2,Nunes-Nogueira V S1

Affiliation:

1. 1Department of Internal Medicine, Botucatu Medical School, State University/UNESP, Sao Paulo, Brazil

2. 2Endocrine Division (SEMPR), Department of Internal Medicine, Federal University of Parana, Curitiba, Brazil

Abstract

Objective To compare the acromegaly mortality rates with those expected for the general population from studies published before and after 2008. Methods We performed a systematic review and included observational studies in which the number of deaths observed in acromegaly was compared with the expected mortality for the general population mortality observed/expected (O/E). The following electronic databases were used as our data sources: EMBASE, MEDLINE and LILACS. From the observed and expected deaths, we recalculated all standardized mortality ratios (SMR) and their respective confidence intervals (95% CI), which were plotted in a meta-analysis using the software RevMan 5.3. Results We identified 2303 references, and 26 studies fulfilled our eligibility criteria. From the 17 studies published before 2008, the mortality in acromegaly was increased, while from the nine studies published after 2008, the mortality was not different from the general population (SMR: 1.35, CI: 0.99–1.85). In six studies where somatostatin analogs (SAs) were used as adjuvant treatment, acromegaly mortality was not increased (SMR: 0.98, CI: 0.83–1.15), whereas in series including only patients treated with surgery and/or radiotherapy, mortality was significantly higher (SMR: 2.11; CI: 1.54–2.91). In studies published before and after 2008, the mortality was not increased in patients who achieved biochemical control, while it was higher in those with active disease. Cancer has become a leader cause of deaths in acromegaly patients in the last decade, period in which life expectancy improved. Conclusion Mortality in acromegaly is normalized with biochemical control and decreased in the last decade with the more frequent use of SAs as adjuvant therapy. Increased life expectancy has been associated with more deaths due to cancer.

Publisher

Bioscientifica

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism

Reference88 articles.

1. Acromegaly: an epidemiological study;Journal of Endocrinological Investigation,1993

2. BoguszewskiCLAyukJ of endocrine disease acromegaly and cancer an old debate revisited of https org;Management European Journal Endocrinology

3. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly;Journal of Clinical Endocrinology and Metabolism,1998

4. Determinants of survival in treated acromegaly in a single center: predictive value of serial insulin-like growth factor I measurements;Journal of Clinical Endocrinology and Metabolism,2004

5. Acromegaly;Clinical Endocrinology,1987

Cited by 140 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3